Disoxaril

This classification denotes an antiviral agent with the molecular formula C20H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FX8Q9PI4VP, chemically known as 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole but generally known as disoxaril, which bears US NIH Compound Identifier 55717. European Medicines Agency schedules Disoxaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06322MIG. The term DISOXARIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). DISOXARIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule disoxaril under HS 29349990 and SITC 51579. As of Q4 2014, DISOXARIL remains the US FDA Preferred Term for this commodity. Disoxaril bears US NLM identifiers UMLS ID C0058467 and NCI Concept Code C81607. SMILES: O(CCCCCCCC1ONC(C1)C)C1CCC(C2=NCCO2)CC1.